TITLE

Use of Medroxyprogesterone Acetate as a Contraceptive in conjunction with Early Postpartum Rubella Vaccination

AUTHOR(S)
Sharp, David S.; Macdonald, Helen
PUB. DATE
November 1973
SOURCE
British Medical Journal;11/24/1973, Vol. 4 Issue 5890, p443
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108909

 

Related Articles

  • Effect of depot medroxyprogesterone acetate on vaginal bleeding in the puerperium. Murphy, H.M. // British Medical Journal;12/1/1979, Vol. 2 Issue 6202, p1400 

    Examines the effect of depot medroxyprogesterone acetate (DMPA) associated to vaginal bleeding in puerperium. Intervention of DMPA postpartum; Effectiveness of DMPA as a contraceptive; Availability of the method to patients use.

  • Long-acting Contraception for Pain Control in Patients with Endometriosis. Edelman, Alison // OB/GYN Clinical Alert;Apr2009, Vol. 25 Issue 12, p91 

    After 6 months of use, both depot medroxyprogesterone acetate and the contraceptive implant (Implanon®) significantly decreased pain associated with endometriosis.

  • Bone density in women receiving depot medroxprogesterone acetate for contraception. Cundy, Tim; Evans, Margaret; Roberts, Helen; Wattie, Diana; Ames, Ruth; Reid, Ian R. // BMJ: British Medical Journal (International Edition);7/6/91, Vol. 303 Issue 6793, p13 

    Examines the use of injectable contraceptive depot medroxyprogesterone acetate in women. Implications of injectable contraceptives; Assessment of bone mineral density by energy x-ray absorptiometry; Effects of contraceptives to bone density in women.

  • Depo-Provera: An injectable contraceptive. Earl, Daniel Thad; David, Daniel J. // American Family Physician;3/1/1994, Vol. 49 Issue 4, p891 

    Discusses the use of medroxyprogesterone acetate (Depo-Provera) as an injectable contraceptive. Indications and advantages; Dosage and administration; Contraindications; Side effects; Case studies on the use of the drug. INSET: Depo-provera--an injectable contraceptive..

  • Research eyes DMPA, cancer risks/benefits.  // Contraceptive Technology Update;Jul2012, Vol. 33 Issue 7, p80 

    The article discusses research reported in the article "Choosing a Contraceptive: Efficacy, Safety, and Personal Considerations" by J. Trussell and K. A. Guthrie, which found that there is an increased cancer risk associated with using the injectable contraceptive depot medroxyprogesterone acetate.

  • New contraceptive eligibility checklists for provision of combined oral contraceptives and... Stang, Amanda; Schwingl, Pamela // Bulletin of the World Health Organization;2000, Vol. 78 Issue 8, p1015 

    Examines the contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community programs. Evaluation of checklists used for eligibility criteria; Checklist development, review and revision; Field-testing.

  • New research emerges on DMPA fracture risks.  // Contraceptive Technology Update;May2013, Vol. 34 Issue 5, p53 

    The article describes a study which found a small increase in the risk of bone fractures in women who used the contraceptive injection depot medroxyprogesterone acetate (DMPA), but researchers did not attribute the risk to the drug itself.

  • Does Injectable Contraceptive Cause Bone Loss in Women? Walling, Anne D. // American Family Physician;5/15/1999, Vol. 59 Issue 10, p2890 

    Presents an excerpt from the study `Bone Mineral Density in Women Using Depot Medroxyprogesterone Acetate for Contraception,' by D. Scholes et al which appeared in the February 1999 issue of `Obstetrics & Gynecology.'

  • Does DMPA use increase fracture risk in women?  // Contraceptive Technology Update;Nov2010, Vol. 31 Issue 11, p125 

    The article discusses research which was conducted on a population of women between the ages of 20-44 and which suggests that use of the contraceptive injection depot medroxyprogesterone acetate (DMPA) Is associated with an increased risk of fractures.

  • Injectable use and bone density. Althaus, Frances // International Family Planning Perspectives;Jun99, Vol. 25 Issue 2, p59 

    Discusses the abstract entitled `Bone density among long-term users of medroxyprogesterone acetate as a contraceptive,' by L.C. Paiva, A.M. Pinto-Neto et al published in the 1998 issue of `Contraception'. Decrease of bone mass as a result of long-term use of injection contraceptive...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics